Original Research
Published on 31 Jan 2024
Is the current therapeutic dosage of nadroparin adequate for neonates and infants under 8 months with thromboembolic disease? a population pharmacokinetic study from a national children’s medical center
in Cardiovascular and Smooth Muscle Pharmacology
- 1,420 views